Paper42530482
A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies.
Li Y and 5 others. Stat Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies. Papers, record 42530482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42530482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptive Clinical Trials as Topic | Major topic |
| Research Design | Major topic |
| Bayes Theorem | |
| Humans | |
| Computer Simulation | |
| Models, Statistical | |
| Alcoholism |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5U24AA026969 | NIH HHS | United States | U24AA026969 | PubMed | NIH RePORTER |
| R01 GM150808 | NIGMS NIH HHS | United States | R01GM150808 | PubMed | NIH RePORTER |
| P30 CA082709 | NCI NIH HHS | United States | P30CA082709 | PubMed | NIH RePORTER |
| 5R01GM150808 | NIH HHS | United States | R01GM150808 | PubMed | NIH RePORTER |
| U24 AA026969 | NIAAA NIH HHS | United States | U24AA026969 | PubMed | NIH RePORTER |
| P30CA082709 | NIH HHS | United States | P30CA082709 | PubMed | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30739965 | A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes. | J Am Stat Assoc | 2018 | https://conductscience.org/library/papers/30739965 | PubMed |
| 2 | 36161762 | A Bayesian phase I/II design to determine subgroup-specific optimal dose for immunotherapy sequentially combined with radiotherapy. | Pharm Stat | 2023 | https://conductscience.org/library/papers/36161762 | PubMed |
| 3 | 11172350 | A model to predict survival in patients with end-stage liver disease. | Hepatology | 2001 | https://conductscience.org/library/papers/11172350 | PubMed |
| 4 | 11460223 | MELD and PELD: application of survival models to liver allocation. | Liver Transpl | 2001 | https://conductscience.org/library/papers/11460223 | PubMed |
| 5 | 37721513 | SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials. | Biometrics | 2023 | https://conductscience.org/library/papers/37721513 | PubMed |
| 6 | 17763973 | A review of phase 2-3 clinical trial designs. | Lifetime Data Anal | 2008 | https://conductscience.org/library/papers/17763973 | PubMed |
| 7 | 38342441 | Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis. | J Hepatol | 2024 | https://conductscience.org/library/papers/38342441 | PubMed |
| 8 | 22826199 | Optimal design of multi-arm multi-stage trials. | Stat Med | 2012 | https://conductscience.org/library/papers/22826199 | PubMed |
| 9 | 28589563 | BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints. | Stat Med | 2017 | https://conductscience.org/library/papers/28589563 | PubMed |
| 10 | 21318084 | Bayesian Models and Decision Algorithms for Complex Early Phase Clinical Trials. | Stat Sci | 2010 | https://conductscience.org/library/papers/21318084 | PubMed |
| 11 | 35363500 | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Circulation | 2022 | https://conductscience.org/library/papers/35363500 | PubMed |
| 12 | 30115921 | Alcoholic liver disease. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/30115921 | PubMed |
| 13 | 16281458 | Dynamic treatment regimes: practical design considerations. | Clin Trials | 2004 | https://conductscience.org/library/papers/16281458 | PubMed |
| 14 | 7980801 | Practical Bayesian guidelines for phase IIB clinical trials. | Biometrics | 1994 | https://conductscience.org/library/papers/7980801 | PubMed |
| 15 | 38055648 | Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis. | Hepatol Commun | 2023 | https://conductscience.org/library/papers/38055648 | PubMed |
| 16 | 28459138 | Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study. | Hepatology | 2017 | https://conductscience.org/library/papers/28459138 | PubMed |
| 17 | 29199843 | Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness. | Psychol Addict Behav | 2017 | https://conductscience.org/library/papers/29199843 | PubMed |
| 18 | 25901427 | Prednisolone or pentoxifylline for alcoholic hepatitis. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25901427 | PubMed |
| 19 | 25811018 | Adaptive clinical trial designs in oncology. | Chin Clin Oncol | 2014 | https://conductscience.org/library/papers/25811018 | PubMed |
| 20 | 9280033 | Bayesian interim analysis of phase II cancer clinical trials. | Stat Med | 1997 | https://conductscience.org/library/papers/9280033 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42804611 | Therapies for alcohol use disorder in alcohol-associated hepatitis clinical trials: Integrated trial design with a composite clinical outcome as the primary endpoint. | Hepatology | 2026 | https://conductscience.org/library/papers/42804611 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42530482
GET https://conductscience.org/api/papers/v1/42530482/references?page=2